Literature DB >> 11401080

Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b.

C Armbruster1, A Kreuzer, H Vorbach, M Huber, C Armbruster1.   

Abstract

In contrast to uncomplicated juvenile laryngeal papillomas which may regress spontaneously, papillomatosis involving pulmonary parenchyma is associated with a poor outcome. This report represents the case of a 34 yr-old female in whom respiratory papillomatosis resulted in voice problems and recurrent pneumonias due to bronchial obstruction. A computed tomographic scan of the chest showed worsening bilateral round cavitating consolidations. Bronchoscopy revealed polypoid lesions of the right vocal cord and the midtrachea which were confirmed as squamous papillomatosis by histology. Interferon (IFN)alpha-2b treatment was inefficient as was cidofovir monotherapy on a maintenance basis. Six months of IFN-alpha-2b and cidofovir in combination led to a complete macroscopic disappearance of the laryngeal lesions and to an impressive regression of the tracheal papillomas and of the intrapulmonary consolidations. These data provide support that severe respiratory papillomatosis can be safely treated by interferon alpha-2b and cidofovir in combination. Probably the same mechanisms as in ribavirin plus interferon alpha-2b, in the treatment of patients with chronic hepatitis C, are responsible for the therapeutic success in this case.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401080     DOI: 10.1183/09031936.01.17408300

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

1.  Pulmonary spread of laryngeal papillomatosis: radiological findings.

Authors:  Katsumi Abe; Yoshiaki Tanaka; Motoichiro Takahashi; Shigeru Kosuda; Katsumi Hayashi; Tetsuya Tanabe; Yoshie Iwasaki; Shinsuke Aida; Toshio Kawauchi; Masayoshi Yamamoto; Tamotsu Kita; Tatsumi Kaji
Journal:  Radiat Med       Date:  2006-05

Review 2.  Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Authors:  Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

3.  Alpha interferon augments cidofovir's antiviral and antiproliferative activities.

Authors:  Jeffrey A Johnson; J David Gangemi
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 4.  Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.

Authors:  Ferdinand I Broekema; Frederik G Dikkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-06       Impact factor: 2.503

5.  Bronchial HPV; the good the bad and the unknown.

Authors:  Paul Zarogoulidis; Stavros Tryfon; Konstantinos Sapalidis; Kosmas Tsakiridis; Sofia Baka; Haidong Huang; Chong Bai; Wolfgang Hohenforst-Schmidt; Dimitris Hatzibougias; Evaggelia Athanasiou; Anastasios Vagionas; Maria Saroglou; Christoforos Kosmidis
Journal:  Respir Med Case Rep       Date:  2020-04-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.